Entwicklung eines Prototyps für die Point-of-Care-Diagnostik von Blutammoniak
Beschreibung
Hyperammonemia and associated neurological manifestations (hepatic encephalopathy) lead to coma and death and incur high costs. It affects 30-45% of cirrhotic patients. A novel portable point of care device based on pH-gradient polymersomes for daily monitoring of ammonia will alleviate the burdens.
Eckdaten
Projektleitung
Stellv. Projektleitung
Projektteam
Dr. Fabrizio Spano, Raphael Hagen, Jan Zwicky, Christian Grossmann Aybar
Projektpartner
Versantis AG
Projektstatus
abgeschlossen, 04/2022 - 01/2025
Institut/Zentrum
Institute of Computational Physics (ICP)
Drittmittelgeber
Innosuisse
Projektvolumen
567'592 CHF
School of Engineering
Technikumstrasse 71
8400 Winterthur